Table 3.

Fasting Plasma Lipoprotein Composition and Markers of Cholesterol Synthesis

	Women (n = 11)	Men (n = 11)
Total FC, mmol/L	1.09 ± 0.15	1.09 ± 0.15
VLDL-FC, mmol/L	0.09 ± 0.05	0.18 ± 0.08a
LDL-FC, mmol/L	0.67 ± 0.12	0.66 ± 0.15
HDL-FC, mmol/L	0.33 ± 0.06	0.25 ± 0.05a
Total EC, mmol/L	4.09 ± 0.57	3.69 ± 0.54
VLDL-EC, mmol/L	0.14 ± 0.09	0.36 ± 0.32b
LDL-EC, mmol/L	2.58 ± 0.52	2.38 ± 0.53
HDL-EC, mmol/L	1.37 ± 0.26	0.95 ± 0.28a
VLDL-TG/VLDL-ApoBc	20 409 ± 8834	12 751 ± 8070b
VLDL-EC/VLDL-ApoBc	9326 ± 16 138	6490 ± 5047
VLDL-FC/VLDL-ApoBc	6689 ± 2936	4571 ± 3180
Cholesterol synthesis: lathosterol/TCc	0.97 ± 0.42	1.37 ± 0.88
Intestinal cholesterol absorption: sitosterol/TCc	1.61 ± 0.4	1.65 ± 0.60
Intestinal cholesterol absorption: campesterol/TCc	1.87 ± 0.64	2.14 ± 1.35
Bile acid synthesis: C4/TCc	7.81 ± 8.07	11.93 ± 14.49

Abbreviations: EC, esterified cholesterol; FC, free cholesterol; LDL, low-density lipoprotein. Data are expressed as mean ± SD.

^aP < 0.01, independent t test, women vs men.

^bP < 0.05, independent t test, women vs men.

^cMolar ratio.